Yoga Intervention for Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
DOI:
https://doi.org/10.48165/IRJAY.2025.81011Keywords:
Insulin Resistance, Meta-Analysis, Polycystic Ovary Syndrome, Systematic Review, Yoga TherapyAbstract
Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age, characterized by insulin resistance, hyperandrogenism, and menstrual irregularities, which contribute to both metabolic and psychological challenges. Yoga therapy, as a holistic mind–body intervention, may provide benefits, although the evidence requires updating. This study aimed to assess the impact of yoga therapy on metabolic, endocrine, reproductive, and psychological outcomes in women with PCOS through a systematic review and meta analysis of randomized controlled trials (RCTs). Methods: Following the PRISMA 2020 guidelines, we searched PubMed, Embase, Cochrane, Scopus, and Google Scholar from January 2020 to May 2025 for RCTs on yoga for PCOS. Two reviewers screened the data, extracted the data, and assessed the risk of bias (RoB). Random-effects meta-analysis pooled outcomes and grading of recommendations assessment, development, and evaluation was used to evaluate certainty. Results: Eight RCTs involving 632 participants were included (median n = 52; moderate RoB). Yoga reduced metabolic homeostatic model assessment of insulin resistance (mean difference [MD] −0.58, 95% confidence interval [CI] −1.05–−0.11; I2 = 0%; moderate certainty), fasting insulin (MD −15.2 pmol/L, 95% CI −25.4–−5.0; I2 = 15%), testosterone (MD −10.44 ng/dL, 95% CI −14.12–−6.76; I2=19%), and depression (MD −4.69, 95% CI −5.63–−3.76; I2 = 75%; low certainty). Menstrual regularity improved (RR 1.45, 95% CI 1.10–1.92; I2 = 20%; moderate certainty). The effects on BMI and glucose levels were modest and uncertain. The subgroups showed greater benefits at ≥12 weeks/≥150 min/week. No adverse events. Conclusion: Yoga has demonstrated modest improvements in outcomes for individuals with PCOS, with moderate certainty regarding its metabolic and endocrine benefits. As a safe adjunctive therapy, it merits consideration for integration into patient care in the future. To confirm these findings over the long term, large multicenter RCTs with standardized protocols are required.Downloads
References
Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2(1):16057. doi: 10.1038/nrdp.2016.57
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ, International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602-18. doi: 10.1093/humrep/dey256
Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841-55. doi: 10.1093/humrep/dew218
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25. doi: 10.1016/j.fertnstert.2003.10.004
Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications. Endocr Rev. 2012;33(6):981-1030. doi: 10.1210/er.2011-1034
Escobar-Morreale HF. Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270-84. doi: 10.1038/nrendo.2018.24
Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update. 2014;20(5):748-58. doi: 10.1093/humupd/dmu012
Macut D, Bjekić-Macut J, Savić-Radojević A. Dyslipidemia and oxidative stress in PCOS. Front Horm Res. 2012;40:51-63. doi: 10.1159/000341683
Benson S, Janssen OE, Hahn S, Tan S, Dietz T, Mann K, Pleger K, Schedlowski M, Arck PC, Elsenbruch S. Disturbed stress responses in women with polycystic ovary syndrome. Psychoneuroendocrinology. 2009;34(5):727-35. doi: 10.1016/j.psyneuen.2008.12.001
Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019;3(3):CD007506. doi: 10.1002/14651858.CD007506.pub4
Lord JM, Tang T, Yasmin E, Norman RJ, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6
Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK, Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-92. doi: 10.1210/jc.2013-2350
Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BG, Wong JL, Norman RJ, Costello MF, Guideline Development Groups. Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline. Med J Aust. 2011;195(6):S65-112. doi: 10.5694/mja11.10915
Vrbikova J, Hainer V. Obesity and polycystic ovary syndrome. Obes Facts. 2009;2(1):26-35. doi: 10.1159/000194169
Ross A, Thomas S. The health benefits of yoga and exercise: A review of comparison studies. J Altern Complement Med. 2010;16(1):3-12. doi: 10.1089/acm.2009.0044
Cramer H, Lauche R, Langhorst J, Dobos G. Yoga for metabolic syndrome: A systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(18):1982-93. doi: 10.1177/2047487316629031
Saoji AA, Raghavendra BR, Manjunath NK. Effects of yogic breath regulation: A narrative review of scientific evidence. J Ayurveda Integr Med. 2019;10(1):50-8. doi: 10.1016/j.jaim.2018.01.005
Khalsa SBS. Yoga as a therapeutic intervention: A bibliometric analysis of published research studies. Indian J Physiol Pharmacol. 2004;48(3):269-85.
Verma A, Upadhyay V, Saxena V. Effect of yoga therapy on health outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis. Am J Lifestyle Med. 2023;17(1):73-92. doi: 10.1177/15598276211029221
Thakur D, Saurabh Singh S, Tripathi M, Lufang A. Effect of yoga on polycystic ovarian syndrome: A systematic review. J Bodyw Mov Ther. 2021;27:281-6. doi: 10.1016/j.jbmt.2021.02.018
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness L, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71
Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: A key to evidence-based decisions. ACP J Club. 1995;123(3):A12-3.
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi: 10.1186/s13643-016-0384-4
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group, Cochrane Statistical Methods Group. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928
Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, Britten N, Roen K, Duffy S. Guidance on the conduct of narrative synthesis in systematic reviews: A product from the ESRC methods programme Version. Vol. 1. England: Lancaster University; 2006. p. 92.
Purushothaman S, Kumar SN, Ramalingam K, Kumaresan A, Anitha M, Muthukumaran J, Alagesan J. Comparison of yoga asana along with aerobic exercise and aerobic exercise alone for dysmenorrhea among college students with polycystic ovarian syndrome. Indian J Physiother Occup Ther. 2024;18:869-73. doi: 10.37506/onymxd30
Mohseni M, Eghbali M, Bahrami H, Dastaran F, Amini L. Yoga effects on anthropometric indices and polycystic ovary syndrome symptoms in women undergoing infertility treatment: A randomized controlled clinical trial. Evid Based Complement Alternat Med. 2021;2021:5564824. doi: 10.1155/2021/5564824
Nalini G, Elangovan R. Effect of yoga therapy with sattvic diet on endometrial thickness among reproductive girls suffering with polycystic ovary syndrome. Int J Health Sci. 2022;6(S6):3327-34. doi: 10.53730/ijhs.v6nS6.10367
ELBanna MM, Kamel DM, Shaaban A, Botla AM, Hamoda RE. Effect of yoga training and high probiotic food supplements on insulin-resistance in polycystic-ovarian-syndrome: A randomized controlled trial. Int J Kinesiol Sports Sci. 2024;12(3):52-61. doi: 10.7575/aiac.ijkss.v.12n.3p.52
Selvaraj V, Vanitha J, Dhanaraj FM, Sekar P, Babu AR. Impact of yoga and exercises on polycystic ovarian syndrome risk among adolescent schoolgirls in South India. Health Sci Rep. 2020;3(4):e212. doi: 10.1002/hsr2.212
Shetty B, Shetty GB, Nanjeshgowda HL, Shetty P. A randomized controlled trial in obese adults with polycystic ovarian syndrome: Examining the impact of short-term integrated naturopathy and yoga interventions on testosterone, oxidative stress, and mental health. Int J Yoga. 2024;17(3):195-202. doi: 10.4103/ijoy.ijoy_180_24
Kumari D, Kumar M, Upadhyay AD, Malhotra N, Mahey R, Dadhwal V, Sehgal T, Mishra R, Dada R. Unveiling therapeutic potential of yoga mitigating oxidative stress and mitochondrial dysfunction in PCOS: A randomized controlled trial. Int J Yoga. 2025;18(1):45-57. doi: 10.4103/ijoy.ijoy_212_24
Gandhi P, Parmar R, Patel G. Effect of fertility massage versus yoga in polycystic ovarian syndrome. Parul Univ J Health Sci Res. 2022;1(1):25-31.

